I-cell disease (Mucolipidosis II). 2000

M Kabra, and S Gulati, and M Kaur, and J Sharma, and A Singh, and V Chopra, and P S Menon, and V Kalra
Department of Pediatrics, All India Institute of Medical Sciences, New Delhi.

I-cell disease (Mucolipidosis II) is one of the lysosomal storage diseases which presents in the neonatal period, and within six months will phenotypically resemble the severe forms of the group of disorders called the "mucopolysaccharidoses" but without mucopolysacchariduria. In Mucolipidosis II, fibrocytes exhibit "abnormal lysosomes". Activities of several lysosomal enzymes are low in fibroblast cultures but high in mucolipidosis II serum. We present a patient with I-cell disease diagnosed on the basis of clinical, radiological and biochemical features. The mother of this child was pregnant and the fetus was also found to be affected.

UI MeSH Term Description Entries
D009081 Mucolipidoses A group of inherited metabolic diseases characterized by the accumulation of excessive amounts of acid mucopolysaccharides, sphingolipids, and/or glycolipids in visceral and mesenchymal cells. Abnormal amounts of sphingolipids or glycolipids are present in neural tissue. INTELLECTUAL DISABILITY and skeletal changes, most notably dysostosis multiplex, occur frequently. (From Joynt, Clinical Neurology, 1992, Ch56, pp36-7) Cherry Red Spot Myoclonus Syndrome,Ganglioside Sialidase Deficiency Disease,I-Cell Disease,Lipomucopolysaccharidosis,Mucolipidosis,Myoclonus Cherry Red Spot Syndrome,Pseudo-Hurler Polydystrophy,Sialidosis,Cherry Red Spot-Myoclonus Syndrome,Deficiency Disease, Ganglioside Sialidase,Glycoprotein Neuraminidase Deficiency,Inclusion Cell Disease,Mucolipidosis I,Mucolipidosis II,Mucolipidosis III,Mucolipidosis III Alpha Beta,Mucolipidosis IIIa,Mucolipidosis IV,Mucolipidosis Type 1,Mucolipidosis Type I,Mucolipidosis Type II,Mucolipidosis Type III,Mucolipidosis Type IV,Myoclonus-Cherry Red Spot Syndrome,Psuedo-Hurler Disease,Sialolipidosis,Type I Mucolipidosis,Type II Mucolipidosis,Type III Mucolipidosis,Type IV Mucolipidosis,Deficiencies, Glycoprotein Neuraminidase,Deficiency, Glycoprotein Neuraminidase,Glycoprotein Neuraminidase Deficiencies,I Cell Disease,I-Cell Diseases,Inclusion Cell Diseases,Lipomucopolysaccharidoses,Mucolipidoses, Type I,Mucolipidoses, Type II,Mucolipidoses, Type III,Mucolipidoses, Type IV,Mucolipidosis, Type I,Mucolipidosis, Type II,Mucolipidosis, Type III,Mucolipidosis, Type IV,Polydystrophy, Pseudo-Hurler,Pseudo Hurler Polydystrophy,Psuedo Hurler Disease,Psuedo-Hurler Diseases,Sialidoses,Sialolipidoses,Type I Mucolipidoses,Type II Mucolipidoses,Type III Mucolipidoses,Type IV Mucolipidoses
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D005315 Fetal Diseases Pathophysiological conditions of the FETUS in the UTERUS. Some fetal diseases may be treated with FETAL THERAPIES. Embryopathies,Disease, Fetal,Diseases, Fetal,Embryopathy,Fetal Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001619 beta-N-Acetylhexosaminidases A hexosaminidase specific for non-reducing N-acetyl-D-hexosamine residues in N-acetyl-beta-D-hexosaminides. It acts on GLUCOSIDES; GALACTOSIDES; and several OLIGOSACCHARIDES. Two specific mammalian isoenzymes of beta-N-acetylhexoaminidase are referred to as HEXOSAMINIDASE A and HEXOSAMINIDASE B. Deficiency of the type A isoenzyme causes TAY-SACHS DISEASE, while deficiency of both A and B isozymes causes SANDHOFF DISEASE. The enzyme has also been used as a tumor marker to distinguish between malignant and benign disease. beta-N-Acetylhexosaminidase,N-Acetyl-beta-D-hexosaminidase,beta-Hexosaminidase,beta-N-Acetyl-D-hexosaminidase,beta-N-Acetyl-hexosaminidase,N Acetyl beta D hexosaminidase,beta Hexosaminidase,beta N Acetyl D hexosaminidase,beta N Acetyl hexosaminidase,beta N Acetylhexosaminidase,beta N Acetylhexosaminidases

Related Publications

M Kabra, and S Gulati, and M Kaur, and J Sharma, and A Singh, and V Chopra, and P S Menon, and V Kalra
January 2005, Journal of postgraduate medicine,
M Kabra, and S Gulati, and M Kaur, and J Sharma, and A Singh, and V Chopra, and P S Menon, and V Kalra
January 1974, Birth defects original article series,
M Kabra, and S Gulati, and M Kaur, and J Sharma, and A Singh, and V Chopra, and P S Menon, and V Kalra
May 1973, Postgraduate medical journal,
M Kabra, and S Gulati, and M Kaur, and J Sharma, and A Singh, and V Chopra, and P S Menon, and V Kalra
February 1975, Orvosi hetilap,
M Kabra, and S Gulati, and M Kaur, and J Sharma, and A Singh, and V Chopra, and P S Menon, and V Kalra
March 1973, Journal de radiologie, d'electrologie, et de medecine nucleaire,
M Kabra, and S Gulati, and M Kaur, and J Sharma, and A Singh, and V Chopra, and P S Menon, and V Kalra
January 1973, Archives francaises de pediatrie,
M Kabra, and S Gulati, and M Kaur, and J Sharma, and A Singh, and V Chopra, and P S Menon, and V Kalra
September 1988, Polski tygodnik lekarski (Warsaw, Poland : 1960),
M Kabra, and S Gulati, and M Kaur, and J Sharma, and A Singh, and V Chopra, and P S Menon, and V Kalra
December 1974, Pediatrics,
M Kabra, and S Gulati, and M Kaur, and J Sharma, and A Singh, and V Chopra, and P S Menon, and V Kalra
February 1983, Clinical genetics,
M Kabra, and S Gulati, and M Kaur, and J Sharma, and A Singh, and V Chopra, and P S Menon, and V Kalra
June 1978, Minerva pediatrica,
Copied contents to your clipboard!